Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Midtvedt

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 9, 2018
Donor-derived strongyloidiasis after organ transplantation in NorwayEspen Nordheim, Monica Olafsson Storrø, Ane Kristine Natvik, et al.
Transplantation Direct|March 30, 2022
A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective StudyVasiliki Tsarpali, Karsten Midtvedt, Kjersti Lønning, et al.
Transplantation|July 25, 2006
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipientsAnders Asberg, Karsten Midtvedt, Pål D Line, et al.
Diabetes Care|March 14, 2019
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes MellitusThea Anine Strøm Halden, Kine Eide Kvitne, Karsten Midtvedt, et al.
Transplantation|July 8, 2014
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipientsHege Pihlstrøm, Geir Mjøen, Dag Olav Dahle, et al.
Transplantation|February 17, 2017
Association Between Pretransplant Cancer and Survival in Kidney Transplant RecipientsDag Olav Dahle, Tom Grotmol, Torbjørn Leivestad, et al.
British Journal of Clinical Pharmacology|January 12, 2020
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantationRolf Anton Klaasen, Stein Bergan, Sara Bremer, et al.
Clinical Transplantation|February 4, 2015
One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allograftsChristina Dörje, Geir Mjøen, Erik H Strøm, et al.
Transplantation Direct|November 18, 2024
Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post-TacrolimusOle Martin Drevland, Marte Grasdal, Rasmus K Carlsen, et al.
Transplantation|October 28, 2003
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?Karsten Midtvedt, Per Fauchald, Stein Bergan, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 9, 2018
Donor-derived strongyloidiasis after organ transplantation in NorwayEspen Nordheim, Monica Olafsson Storrø, Ane Kristine Natvik, et al.
Transplantation Direct|March 30, 2022
A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective StudyVasiliki Tsarpali, Karsten Midtvedt, Kjersti Lønning, et al.
Transplantation|July 25, 2006
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipientsAnders Asberg, Karsten Midtvedt, Pål D Line, et al.
Diabetes Care|March 14, 2019
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes MellitusThea Anine Strøm Halden, Kine Eide Kvitne, Karsten Midtvedt, et al.
Transplantation|July 8, 2014
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipientsHege Pihlstrøm, Geir Mjøen, Dag Olav Dahle, et al.
Transplantation|February 17, 2017
Association Between Pretransplant Cancer and Survival in Kidney Transplant RecipientsDag Olav Dahle, Tom Grotmol, Torbjørn Leivestad, et al.
British Journal of Clinical Pharmacology|January 12, 2020
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantationRolf Anton Klaasen, Stein Bergan, Sara Bremer, et al.
Clinical Transplantation|February 4, 2015
One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allograftsChristina Dörje, Geir Mjøen, Erik H Strøm, et al.
Transplantation Direct|November 18, 2024
Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post-TacrolimusOle Martin Drevland, Marte Grasdal, Rasmus K Carlsen, et al.
Transplantation|October 28, 2003
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?Karsten Midtvedt, Per Fauchald, Stein Bergan, et al.
Pageof 16